Empro Group Inc. Ordinary shares (EMPG)vsHenry Schein Inc (HSIC)
EMPG
Empro Group Inc. Ordinary shares
$17.36
0.00%
HEALTHCARE · Cap: $143.05M
HSIC
Henry Schein Inc
$74.25
+0.31%
HEALTHCARE · Cap: $8.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Henry Schein Inc generates 240278% more annual revenue ($13.18B vs $5.48M). EMPG leads profitability with a 13.7% profit margin vs 3.0%. HSIC trades at a lower P/E of 22.6x. HSIC earns a higher WallStSmart Score of 56/100 (C).
EMPG
Hold47
out of 100
Grade: D+
HSIC
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-2745.9%
Fair Value
$0.61
Current Price
$17.36
$16.75 premium
Margin of Safety
+12.5%
Fair Value
$93.39
Current Price
$74.25
$19.14 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 66 in profit
Strong operational efficiency at 36.1%
Revenue surging 141.6% year-over-year
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Areas to Watch
Trading at 17.0x book value
0.0% earnings growth
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
Expensive relative to growth rate
3.0% margin — thin
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : EMPG
The strongest argument for EMPG centers on Return on Equity, Operating Margin, Revenue Growth. Revenue growth of 141.6% demonstrates continued momentum.
Bull Case : HSIC
The strongest argument for HSIC centers on Price/Book.
Bear Case : EMPG
The primary concerns for EMPG are Price/Book, EPS Growth, Market Cap. A P/E of 192.9x leaves little room for execution misses.
Bear Case : HSIC
The primary concerns for HSIC are PEG Ratio, Profit Margin, Debt/Equity. Thin 3.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
EMPG profiles as a growth stock while HSIC is a value play — different risk/reward profiles.
EMPG is growing revenue faster at 141.6% — sustainability is the question.
HSIC generates stronger free cash flow (338M), providing more financial flexibility.
Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HSIC scores higher overall (56/100 vs 47/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Empro Group Inc. Ordinary shares
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Empro Group Inc., through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company is headquartered in Shah Alam, Malaysia.
Visit Website →Henry Schein Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?